{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["3(20)"],"submitter":["Kamdar M"],"funding":["NCI NIH HHS"],"journal":["Blood advances"],"pagination":["3132-3135"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC6849956"],"repository":["biostudies-literature"],"pubmed_title":["Five-year outcomes of the S1106 study of R-hyper-CVAD vs R-bendamustine in transplant-eligible patients with mantle cell lymphoma."],"pmcid":["PMC6849956"],"funding_grant_id":["UG1 CA233324","U10 CA180819","UG1 CA233339","UG1 CA233160","U10 CA180888","UG1 CA233373"],"pubmed_authors":["Li H","Barr PM","Shea TC","Kamdar M","Friedberg JW","Fenske TS","Chen RW","Leblanc ML","Phillips TJ","Rimsza LM","Kahl BS","Leonard JP","Smith SM"],"additional_accession":[]},"is_claimable":false,"name":"Five-year outcomes of the S1106 study of R-hyper-CVAD vs R-bendamustine in transplant-eligible patients with mantle cell lymphoma.","description":null,"dates":{"release":"2019-01-01T00:00:00Z","publication":"2019 Oct","modification":"2025-04-19T09:12:00.657Z","creation":"2025-04-19T09:12:00.657Z"},"accession":"S-EPMC6849956","cross_references":{"pubmed":["31648328"],"doi":["10.1182/bloodadvances.2019000526"]}}